About 315,000 results
Open links in new tab
Weight-loss drug developer BioAge raises $198 mln in U.S. IPO
BioAge stock rallies 29% following upsized $198M IPO
BioAge Labs Announces Pricing of Upsized Initial Public Offering
BioAge Labs IPO: stock price today in high-profile Nasdaq debut
BioAge prices $198M IPO, validating pivot to obesity drug research
Obesity drug developer BioAge raises $198m in IPO
Obesity drug developer BioAge Labs aims up to $640 mln …
BioAge Labs Files For $100M IPO, Becomes The New Entrant In …
Weight loss drug maker BioAge Labs eyes $200 million IPO - Quartz
Obesity drug developer BioAge seeks up to $587 mln valuation in US IPO
- Some results have been removed